Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Immunoproliferative Disorders × Pharmacogenomic Testing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Lymphoid 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1

Interventions

Pharmacogenomic Testing 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02670564 2019-04-16

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Swiss Pediatric Oncology Group

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡